http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2546135-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c509c10f7993bf4185abf29e4bf8d50 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
filingDate | 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b1730c570190273cd1041ae5f7b550 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d3802f6426ab2078c44330df459aefb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2eca43aaddf7a3d18f54cd579d2536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd59f583f6f164fcdb03dc97a34a9d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_341f23309682d4313ead7dcdac23cab6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de310dcb691bd3e4f390382d803e57d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3930c67d1fd2fe631db458741df155e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e79c531a598d7d2b16bb86e13474ff42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94022f8233e0cce2730b7cf0d3f43a81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5efab9ab7a75af8e1f6a0e3f193ceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a4a8dce375b6905074bb8f284e33387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3872c72800b481c577ab84ad82c90529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60da63663ba24d2417a45fe0be57d7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65c81243d8519c4dd46450f5ac2d0a20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd5f4a56fc1ae92b9e95bebd3334d52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc2652c4f12bfe46eed9700074d30225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b27eedae8eac5e423082279580ed5d3 |
publicationDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2546135-T3 |
titleOfInvention | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
abstract | A compound or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of: trans-4 - {[(4 - {[4- (4 - {[2- (4-chlorophenyl) -4), 4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} -2-nitrophenyl) amino ] methyl} methyl cyclohexanecarboxylate; Trans-4 - {[(4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) - 2- (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl-2-nitrophenyl) amino] methyl} cyclohexanecarboxylic acid; N- (4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H- pyrrolo [2,3-b] pyridin-5- yloxy) benzoyl] sulfamoyl} -2-nitrophenyl) -4-cyanopiperidin-1-carboxamide; 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -N - {[4 - ({[cis-4 - (methoxymethyl) cyclohexyl] methyl} amino) -3-nitrophenyl] sulfonyl} -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -N - {[4 - ({[trans-4 - (methoxymethyl) cyclohexyl] methyl} amino) -3-nitrophenyl] sulfonyl} -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3-b ] pyridin-5-yloxy) -N- {[1- (tetrahydro-2H-pyran-4-ylmethyl) -1H-benzotriazol-5-yl] sulfonyl} benzamide; N - ({5-chloro-6 - [(2-oxo-1-oxa-3-azaspiro [4,5] dec-8-yl) methoxy] pyridin-3-yl} sulfonyl) -4- (4- {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3-b] pyridin-5- yloxy) benzamide; N- (4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H- pyrrolo [2,3-b] pyridin-5- yloxy) benzoyl] sulfamoyl} -2-nitrophenyl) -4-methoxypiperidin-1-carboxamide; N - ({5-chloro-6 - [(2-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-5-yl) methoxy] pyridin-3-yl} sulfonyl) -4- ( 4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3-b] pyridin- 5-yloxy) benzamide; 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3-b ] pyridin-5-yloxy) -N- {[1- (tetrahydro-2H-pyran-4-ylmethyl) -1H-pyrrolo [2,3-b] pyridin-5-yl] sulfonyl} benzamide; 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -N - {[3-chloro-1- (tetrahydro -2H-pyran-4- ylmethyl) -1H-pyrrolo [2,3-b] pyridin-5-yl] sulfonyl} -2- (1H-pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; 4- (4 - {[2- (4-chlorophenyl) -4- (methoxymethyl) -4-methylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -N - ({3-nitro- 4 - [(tetrahydro-2H-pyran-4-ylmethyl) amino] phenyl} sulfonyl) -2- (1H-pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; N - [(4 - {[4,4-bis (hydroxymethyl) cyclohexyl] methoxy} -3-nitrophenyl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1 - en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; N- (2-Chloro-4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2 - (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} phenyl) -4-methoxypiperidin-1-carboxamide; N- (2-Chloro-4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2 - (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} phenyl) -4-cyanopiperidin-1-carboxamide; N- (2-Chloro-4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2 - (H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} phenyl) -4-hydroxy-4-methylpiperidin-1-carboxamide; N- (2-Chloro-4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2 - (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} phenyl) -4- (methoxymethyl) piperidin-1-carboxamide; N - [(5-chloro-6 - {[(5r, 8r) -2-oxo-1-oxa-3-azaspiro [4,5] dec-8-yl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzamide; N - [(5-chloro-6 - {[(5s, 8s) -2-oxo-1-oxa-3-azaspiro [4,5] dec-8-yl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzamide; N- (2-Chloro-4 - {[4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2 - (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzoyl] sulfamoyl} phenyl) -4- (morpholin-4-yl) piperidin-1-carboxamide; N - [(5-chloro-6 - {[trans-4-hydroxy-4- (methoxymethyl) cyclohexyl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; N - [(5-chloro-6 - {[cis-4-hydroxy-4- (hydroxymethyl) cyclohexyl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; N - [(5-chloro-6 - {[trans-4-hydroxy-4- (hydroxymethyl) cyclohexyl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; N - [(5-chloro-6 - {[4-fluoro-1- (oxetan-3-yl) piperidin-4-yl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2 - (4-chlorophenyl) -5-methoxy-5-methylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy )benzamide; 4- (4 - {[2- (4-chlorophenyl) cyclohex-1-en-1-yl] methyl} piperazin-1-yl) -N - ({3-nitro-4 - [(tetrahydro-2H-pyran -4-ylmethyl) amino] phenyl} sulfonyl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide; 4- (4-Chlorophenyl) -1-methyl-3 - [(4- {4 - [({3-nitro-4 - [(tetrahydro-2H-pyran-4-ylmethyl) amino] phenyl} sulfonyl) carbamoyl acid ] -3- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) phenyl} piperazin-1-yl) methyl] cyclohex-3-ene-1-carboxylic acid; and N - [(5-chloro-6 - {[1- (oxetan-3-yl) piperidin-4-yl] methoxy} pyridin-3-yl) sulfonyl] -4- (4 - {[2- (4 -chlorophenyl) -4,4-dimethylcyclohex-1-en-1-yl] methyl} piperazin-1-yl) -2- (1 H -pyrrolo [2,3-b] pyridin-5-yloxy) benzamide. |
priorityDate | 2010-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2329.